Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (3): 321-324    DOI: 10.19485/j.cnki.issn2096-5087.2025.03.024
  妇幼保健 本期目录 | 过刊浏览 | 高级检索 |
番禺区女性乳腺癌患者生存分析
由娜1, 梁小娴1, 赖春燕2, 阮慧红3
1.广州市番禺区慢性病防治站,广东 广州 511400;
2.广州市番禺区疾病预防控制中心,广东 广州 511400;
3.广州市番禺区化龙镇社区卫生服务中心,广东 广州 511400
Survival analysis of female breast cancer patients in Panyu District
YOU Na1, LIANG Xiaoxian1, LAI Chunyan2, RUAN Huihong3
1. Panyu District Center for Chronic Disease Control, Guangzhou, Guangdong 511400, China;
2. Panyu District Center for Disease Control and Prevention, Guangzhou, Guangdong 511400, China;
3. Panyu District Hualong Town Community Health Service Center, Guangzhou, Guangdong 511400, China
全文: PDF(858 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解广州市番禺区女性乳腺癌患者生存率,为改善乳腺癌患者预后提供依据。方法 通过广州市癌症登记报告管理系统收集2017年确诊的番禺区户籍女性乳腺癌患者的年龄、临床分期和手术治疗等基本资料,随访生存情况,随访终点日期为2022年12月31日。采用寿命表法计算生存率,采用多因素Cox比例风险回归模型分析女性乳腺癌患者生存时间的影响因素。结果 2017年番禺区报告女性乳腺癌227例,年龄MQR)为51(17)岁。临床分期为Ⅰ期43例,占18.94%;Ⅱ期55例,占24.23%;Ⅲ期63例,占27.75%;Ⅳ期27例,占11.89%;不明39例,占17.18%。手术治疗204例,占89.87%。化疗73例,占32.16%。截至2022年12月31日,死亡40例,失访14例。1年、3年和5年生存率分别为96.44%、87.45%和82.87%。多因素Cox比例风险回归分析结果显示,年龄大(HR=1.023,95%CI:1.002~1.046)、临床分期为Ⅲ期(HR=10.050,95%CI:1.324~76.270)或Ⅳ期(HR=42.663,95%CI:5.588~325.742)的女性乳腺癌患者死亡风险较高,手术治疗(HR=0.278,95%CI:0.130~0.598)的女性乳腺癌患者死亡风险较低。结论 番禺区女性乳腺癌患者5年生存率为82.87%,年龄、临床分期和手术治疗是女性乳腺癌患者生存时间的主要影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
由娜
梁小娴
赖春燕
阮慧红
关键词 乳腺癌生存率生存分析影响因素    
AbstractObjective To investigate the survival rate of female breast cancer patients in Panyu District, Guangzhou City, so as to provide the basis for improving the prognosis of breast cancer patients. Methods Basic information including age, clinical stage and surgical treatment of female breast cancer patients registered in Panyu District and diagnosed in 2017 were collected through the Guangzhou Municipal Cancer Registration and Reporting Management System, and were followed up until December 31, 2022. The survival rate was calculated using the life table. Factors affecting survival time among female breast cancer patients were analyzed using a multivariable Cox proportional hazard regression model. Results A total of 227 female breast cancer patients were reported in Panyu District in 2017, and had a median age of 51 (interquartile range, 17) years. There were 43 cases (18.94%) in stage Ⅰ, 55 cases (24.23%) in stage Ⅱ, 63 cases (27.75%) in stage Ⅲ, 27 cases (11.89%) in stage Ⅳ, and 39 cases (17.18%) with unknown staging. Surgical treatment was performed in 204 cases (89.87%), and chemotherapy was administered in 73 cases (32.16%). By December 31, 2022, there were 40 deaths and 14 patients lost to follow-up. The one-year, three-year and five-year survival rates were 96.44%, 87.45% and 82.87%, respectively. Multivariable Cox proportional hazard regression analysis showed that older age (HR=1.023, 95%CI: 1.002-1.046), clinical stage Ⅲ (HR=10.050, 95%CI: 1.324-76.270) or IV (HR=42.663, 95%CI: 5.588-325.742) were associated with a higher risk of mortality in female breast cancer patients, while surgical treatment (HR=0.278, 95%CI: 0.130-0.598) was associated with a lower risk of mortality. Conclusions The five-year survival rate of female breast cancer patients in Panyu District was 82.87%. Age, clinical stage and surgical treatment were the main influencing factors for the survival time of female breast cancer patients.
Key wordsbreast cancer    survival rate    survival analysis    influencing factor
收稿日期: 2024-11-18      修回日期: 2025-01-22      出版日期: 2025-03-10
中图分类号:  R737.9  
基金资助:番禺区科技计划项目(2022-Z04-061)
作者简介: 由娜,硕士,副主任医师,主要从事慢性病监测及管理工作
通信作者: 阮慧红,E-mail:37242321@qq.com   
引用本文:   
由娜, 梁小娴, 赖春燕, 阮慧红. 番禺区女性乳腺癌患者生存分析[J]. 预防医学, 2025, 37(3): 321-324.
YOU Na, LIANG Xiaoxian, LAI Chunyan, RUAN Huihong. Survival analysis of female breast cancer patients in Panyu District. Preventive Medicine, 2025, 37(3): 321-324.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.03.024      或      https://www.zjyfyxzz.com/CN/Y2025/V37/I3/321
[1] 曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2021,13(3):63-69.
CAO M M,CHEN W Q.Interpretation on the global cancer statistics of GLOBOCAN 2020[J].Chin J Front Med Sci(Electron Version),2021,13(3):63-69.(in Chinese)
[2] 由娜,阮慧红,邢启明,等.2019年广州市番禺区恶性肿瘤发病与预后[J].热带医学杂志,2022,22(2):278-282.
YOU N,RUAN H H,XING Q M,et al.Cancer incidence and prognosis in Panyu district of Guangzhou,2019[J].J Trop Med,2022,22(2):278-282.(in Chinese)
[3] 健康中国行动推进委员会.健康中国行动(2019—2030年):总体要求、重大行动及主要指标[J].中国循环杂志,2019,34(9):846-858.
Healthy China Action Promotion Committee.Healthy China Action(2019-2030):overall requirements,important actions,and main indicators[J].Chin Circ J,2019,34(9):846-858.(in Chinese)
[4] FELAY J,BURKHARD C,WHELAN S,et al.Check and conversion programs for cancer registries.IARC technical report No.42[R].Lyon:IARC,2005.
[5] PARKIN D M,BRAY F.Evaluation of data quality in the cancer registry:principles and methods Part Ⅱ.Completeness[J].Eur J Cancer,2009,45(5):756-764.
[6] 国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016.
National Cancer Center.Guidelines for cancer registration in China(2016)[M].Beijing:People's Medical Publishing House,2016.(in Chinese)
[7] ZENG H M,CHEN W Q,ZHENG R S,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):555-567.
[8] 魏矿荣,梁智恒,李柱明.2003—2013年广东省中山市主要癌症净生存率分析[J].中国肿瘤,2020,29(2):103-107.
WEI K R,LIANG Z H,LI Z M.Net survival of major cancers in Zhongshan City of Guangdong Province from 2003 to 2013[J].Chin Cancer,2020,29(2):103-107.(in Chinese)
[9] 吴新凡,王临池,张秋,等.苏州市姑苏区2008—2013年恶性肿瘤患者生存分析[J].中国初级卫生保健,2021,35(3):41-44.
WU X F,WANG L C,ZHANG Q,et al.Survival of cancer patients in Gusu District of Suzhou,2008-2013[J].Chin Prim Health Care,2021,35(3):41-44.(in Chinese)
[10] 韩雪,谢梦,赵佳,等.2002—2012年上海市杨浦区女性人群乳腺癌的发病和生存情况分析[J].中华疾病控制杂志,2015,19(7):708-711.
HAN X,XIE M,ZHAO J,et al.The incidence and survival analysis of breast cancer among female residents in Yangpu District of Shanghai from 2002 to 2012[J].Chin J Dis Control Prev,2015,19(7):708-711.(in Chinese)
[11] 陈海珍,徐红,吉光,等.2007—2017年江苏省南通市肿瘤医院乳腺癌住院患者生存率分析[J].中国肿瘤,2023,32(11):820-826.
CHEN H Z,XU H,JI G,et al.Analysis of survival among breast cancer inpatients in Nantong Tumor Hospital from 2007 to 2017[J].Chin Cancer,2023,32(11):820-826.(in Chinese)
[12] 李贺,左婷婷,曾红梅,等.不同年龄女性乳腺癌患者的临床特征及预后分析[J].中华肿瘤杂志,2021,43(1):126-131.
LI H,ZUO T T,ZENG H M,et al.Clinical features and prognostic analysis of female breast cancer in different diagnosed ages[J].Chin J Oncol,2021,43(1):126-131.(in Chinese)
[13] 王军,陈永胜,丁璐璐,等.1972—2016年江苏省启东市女性乳腺癌生存率趋势分析[J].中国肿瘤,2023,32(3):178-183.
WANG J,CHEN Y S,DING L L,et al.Analysis of survival rate trend for female breast cancer in Qidong of Jiangsu,1972-2016[J].Chin Cancer,2023,32(3):178-183.(in Chinese)
[14] 徐巧巧,吕萍,颜波儿.乳腺癌患者术后生命质量及影响因素分析[J].预防医学,2017,29(9):906-908,913.
XU Q Q,LYU P,YAN B E.Quality of life and its influencing factors in patients with breast cancer after operation[J].China Prev Med J,2017,29(9):906-908,913.(in Chinese)
[15] 崔俊鹏,陆艳,黄春妍,等.2007—2021年苏州市女性乳腺癌死亡与减寿分析[J].预防医学,2023,35(5):380-383.
CUI J P,LU Y,HUANG C Y,et al.Death and life loss due to female breast cancer in Suzhou City from 2007 to 2021[J].China Prev Med J,2023,35(5):380-383.(in Chinese)
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 徐光明, 张震, 叶小红. 2015—2024年临海市新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2026, 38(1): 71-74.
[3] 夏子淇, 陈晴晴, 高四海, 吴矛矛. 温州市中小学生营养健康知识调查[J]. 预防医学, 2026, 38(1): 98-101,106.
[4] 陈慧, 苗姗姗, 刘宪峰, 张慧. 新疆生产建设兵团中小学生龋齿现况调查[J]. 预防医学, 2026, 38(1): 102-106.
[5] 吕婧, 徐欣颖, 乔颖异, 石兴龙, 岳芳, 刘营, 程传龙, 张宇琦, 孙继民, 李秀君. 浙江省发热伴血小板减少综合征流行特征及影响因素分析[J]. 预防医学, 2026, 38(1): 10-14.
[6] 陶桃, 张海芳, 凡鹏飞, 李秋华, 陈晓蕾. 丽水市老年肺结核患者治疗转归的影响因素分析[J]. 预防医学, 2025, 37(9): 892-896,902.
[7] 徐艳平, 闫晓彤, 姚丁铭, 徐越, 张雪海, 孙洁, 徐锦杭. 浙江省中老年人肺炎疫苗接种意愿的影响因素研究[J]. 预防医学, 2025, 37(9): 881-885.
[8] 姜艳, 李锦成, 许纯, 杨科佼, 杨文彬, 徐胜. 扬州市MSM人群艾滋病非职业暴露后预防知晓率调查[J]. 预防医学, 2025, 37(9): 903-906,912.
[9] 翟羽佳, 章涛, 古雪, 徐乐, 吴梦娜, 林君芬, 吴晨. 社区老年人认知衰弱现况调查[J]. 预防医学, 2025, 37(8): 762-766,772.
[10] 苏德华, 陈向阳, 李君, 赵丽娜, 张鹤美, 朱婷婷, 胡文雪, 赖江宜. 温州市新报告HIV/AIDS病例抗病毒治疗及时性分析[J]. 预防医学, 2025, 37(8): 804-808.
[11] 严青秀, 王炜, 郝晓刚, 高宇, 方春福, 张幸, 刘文峰. 2017—2023年衢州市肺结核患者未收治情况分析[J]. 预防医学, 2025, 37(8): 799-803.
[12] 王晓宇, 张志平, 董玉颖, 梁杰, 陈强. 老年人带状疱疹疫苗接种意愿的影响因素分析[J]. 预防医学, 2025, 37(8): 809-813.
[13] 王海琪, 张涵潇, 杨凤云, 国献丽, 范生荣, 张丽锋, 蒋泓. 嘉定区中学生抑郁情绪调查[J]. 预防医学, 2025, 37(8): 832-836.
[14] 成灵灵, 阎亚琼, 白增华, 张晓刚, 郝丽婷, 杨慧莹. 先天性甲状腺功能减退症患儿年龄别体质指数Z评分变化轨迹及影响因素[J]. 预防医学, 2025, 37(8): 858-863.
[15] 何欢, 赵雪, 蔡鹏, 詹小亚, 马蕾. 老年慢性阻塞性肺疾病患者运动恐惧的影响因素研究[J]. 预防医学, 2025, 37(7): 659-663.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed